Posts

Posted on

Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for COVID-19 2-Gene Multiplex Test

PR Newswire

SALT LAKE CITY, Nov. 25, 2020 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that CoSara Diagnostics Pvt Ltd (“CoSara,” or the “JV”), its joint venture for manufacturing and sales in India, has received clearance by the Central Drugs Standard Control Organization (“CDSCO”) in India to manufacture and sell its Saragene™ COVID-19 2-gene multiplex RT-PCR test as an in vitro diagnostic (“IVD”), intended for the qualitative detection of the SARS-CoV-2 virus.

The Saragene test kit approved by the CDSCO uses the Company’s patented CoPrimer™ technology and is based on a test originally designed by Co-Diagnostics, who also recently announced receipt of a CE marking for its Logix Smart™ SARS-CoV-2 (genes RdRp/E) multiplex test. Both the CoSara and Co-Diagnostics test target two gene markers of the SARS-CoV-2 genome, RdRp and E-gene, to identify the presence of the virus, and were designed to meet the needs of those markets where government or regulatory bodies recommend a multi-target coronavirus diagnostic.

Dwight Egan, CEO of Co-Diagnostics, commented “Tests built on our CoPrimer technology have several advantages over other platforms, including the enhanced multiplex capabilities. We believe that the highly specific nature of the new Saragene test which follows World Health Organization guidance will help CoSara be able to play an even more active role in the battle against this pandemic.”

CoSara Director Mohal Sarabhai remarked “Our honorable Prime Minister Shri Narendra Modi has endorsed the hike in number of available RT-PCR tests to keep the COVID-19 positivity rate under 5%. With this clearance in place, CoSara is geared up for this challenge by providing affordable, high quality, ‘Made in India‘ 2-gene multiplex COVID-19 RT-PCR tests across the country.”

CoSara has previously received CDSCO clearance for RT-PCR tests for Mycobacterium tuberculosis, malaria, hepatitis B, hepatitis C and human papillomavirus (HPV) to be manufactured and sold as IVDs in the Indian market.

About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets a new, state-of-the-art diagnostics technology. The Company’s technology is utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests to locate genetic markers for use in industries other than infectious disease and license the use of those tests to specific customers.

Forward-Looking Statements:

This press release contains forward-looking statements. Forward-looking statements can be identified by words such as “believes,” “expects,” “estimates,” “intends,” “may,” “plans,” “will” and similar expressions, or the negative of these words. Such forward-looking statements are based on facts and conditions as they exist at the time such statements are made and predictions as to future facts and conditions.  Forward-looking statements in this release include statements regarding the (i) use of funding proceeds, (ii) expansion of product distribution, (iii) acceleration of initiatives in liquid biopsy and SNP detection, (iv) use of the Company’s liquid biopsy tests by laboratories, (v) capital resources and runway needed to advance the Company’s products and markets, (vi) increased sales in the near-term, (vii) flexibility in managing the Company’s balance sheet, (viii) anticipation of business expansion, and (ix) benefits in research and worldwide accessibility of the CoPrimer technology and its cost-saving and scientific advantages. Forward-looking statements are subject to inherent uncertainties, risks and changes in circumstances.  Actual results may differ materially from those contemplated or anticipated by such forward-looking statements. Readers of this press release are cautioned not to rely on any forward-looking statements. Any forward-looking statement made by the Company in this press release is based only on information currently available to the Company and speaks only as of the date on which it is made. The Company does not undertake any obligation to update any forward-looking statement relating to matters discussed in this press release, except as may be required by applicable securities laws.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/co-diagnostics-jv-cosara-receives-clearance-from-indian-fda-for-covid-19-2-gene-multiplex-test-301180716.html

SOURCE Co-Diagnostics

Posted on

Suburban Propane Partners, L.P. Annual Report Available Online

PR Newswire

WHIPPANY, N.J., Nov. 25, 2020 /PRNewswire/ — Suburban Propane Partners, L.P. (NYSE:SPH), a nationwide distributor of propane, fuel oil and related products and services, as well as a marketer of natural gas and electricity, has filed its Annual Report on Form 10-K for its fiscal year ended September 26, 2020 with the Securities and Exchange Commission (“SEC”).

A link to the fiscal 2020 Annual Report on Form 10-K, as filed with the SEC, is available on the Partnership’s website at www.suburbanpropane.com.

Upon written request, the Partnership will provide to any unitholder or noteholder, without charge, a hard copy of its Annual Report on Form 10-K for the year ended September 26, 2020. Requests should be directed to: Suburban Propane Partners, L.P., Investor Relations, P.O. Box 206, Whippany, New Jersey 07981-0206.

Suburban Propane Partners, L.P. is a publicly-traded master limited partnership listed on the New York Stock Exchange. Headquartered in Whippany, New Jersey, Suburban has been in the customer service business since 1928. The Partnership serves the energy needs of approximately 1.0 million residential, commercial, industrial and agricultural customers through approximately 700 locations in 41 states.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/suburban-propane-partners-lp-annual-report-available-online-301180707.html

SOURCE Suburban Propane Partners, L.P.

Posted on

NextGen Healthcare, Inc. to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

NextGen Healthcare, Inc. to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference

IRVINE, Calif.–(BUSINESS WIRE)–NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today announced that President and Chief Executive Officer, Rusty Frantz, and Chief Financial Officer, Jamie Arnold, will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference, including a fireside chat presentation and one-on-one meetings with investors, on Tuesday, December 1, 2020. A recording of the fireside chat will be available at investor.nextgen.com.

About NextGen Healthcare, Inc.

NextGen Healthcare, Inc. (Nasdaq: NXGN) is a leading provider of ambulatory-focused technology solutions. We are empowering the transformation of ambulatory care—partnering with medical, behavioral and oral health providers in their journeys to value-based care to make healthcare better for everyone. We go beyond EHR and PM. Our integrated solutions help increase clinical productivity, enrich the patient experience, and ensure healthy financial outcomes. We believe in better. Learn more at nextgen.com, and follow us on Facebook, Twitter, LinkedIn, YouTube and Instagram.

Press Contact:

Tami Stegmaier

NextGen Healthcare, Inc.

(949) 237-6083

[email protected]

or

Investor Contacts:

Westwicke

Bob East or Asher Dewhurst

443-213-0500

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Mental Health Health Technology Practice Management Managed Care Software Dental

MEDIA:

Logo
Logo
Posted on

Citigroup CFO Mark Mason to Present at the Goldman Sachs 2020 U.S. Financial Services Conference

Citigroup CFO Mark Mason to Present at the Goldman Sachs 2020 U.S. Financial Services Conference

NEW YORK–(BUSINESS WIRE)–
Mark Mason, Chief Financial Officer of Citigroup, will present at the Goldman Sachs 2020 U.S. Financial Services Conference held virtually on Wednesday, December 9, 2020. The presentation is expected to begin at approximately 3:20 p.m. (Eastern). A live webcast will be available at www.citigroup.com/citi/investor. A replay and transcript of the webcast will be available shortly after the event.

Citi

Citi, the leading global bank, has approximately 200 million customer accounts and does business in more than 160 countries and jurisdictions. Citi provides consumers, corporations, governments and institutions with a broad range of financial products and services, including consumer banking and credit, corporate and investment banking, securities brokerage, transaction services, and wealth management.

Additional information may be found at www.citigroup.com | Twitter: @Citi | YouTube: www.youtube.com/citi | Blog: http://blog.citigroup.com | Facebook: www.facebook.com/citi | LinkedIn: www.linkedin.com/company/citi

Media: Brendan McManus (212) 793-7064

Investors: Elizabeth Lynn (212) 559-2718

Fixed Income Investors: Thomas Rogers (212) 559-5091

KEYWORDS: New York United States North America

INDUSTRY KEYWORDS: Banking Other Professional Services Professional Services Finance

MEDIA:

Logo
Logo
Posted on

Lori A. Johnston Named to Farmers & Merchants Bancorp, Inc. Board of Directors

ARCHBOLD, Ohio, Nov. 25, 2020 (GLOBE NEWSWIRE) — Farmers & Merchants Bancorp, Inc. (the “Company”) (NASDAQ: FMAO), the holding company of Farmers & Merchants State Bank (the “Bank”), announced today that the Company’s Board of Directors has increased in size from 12 to 13 members and Lori A. Johnston was appointed to the Board of Directors of both the Company and the Bank.

Ms. Johnston resides in Grand Rapids, Ohio. She is the President of ProMedica Insurance Corporation, an affiliate of ProMedica Health System. She has been employed by ProMedica Health System and affiliates in increasing levels of leadership roles since 1996. Ms. Johnston was employed by Ernst & Young, LLP in Toledo, Ohio from 1983-1996 and is a Certified Public Accountant.

Ms. Johnston is an active member of the Toledo community, serving as a Board Member for various entities including Toledo Mud Hens/Toledo Walleye, Ohio Association of Health Plans, Health Plan Alliance, Compassion Health Toledo and St. Ursula Academy.

“We are extremely pleased to welcome Lori to our Board,” commented Jack Johnson, Board Chairman. “Adding top talent across all areas of the Company, including our Board of Directors, is one of our top strategic initiatives. Lori is a proven leader and will be an asset to our Board and the Company.”

Based on her financial expertise, Ms. Johnston will be serving on the Audit Committee of the Board of Directors.

“Lori will bring great insights across a wide range of experiences to the Board and I look forward to her support as we further the Bank’s growth and financial performance,” said Lars Eller, President and Chief Executive Officer.

About Farmers & Merchants State Bank:

The Farmers & Merchants State Bank is a local independent community bank that has been serving Northwest Ohio and Northeast Indiana since 1897. The Farmers & Merchants State Bank provides commercial banking, retail banking and other financial services through its 30 offices. Our locations are in Fulton, Defiance, Hancock, Henry, Lucas, Williams, and Wood counties in Northwest Ohio. In Northeast Indiana, we have offices located in Adams, Allen, DeKalb, Jay and Steuben counties.

Safe harbor statement

Farmers & Merchants Bancorp, Inc. (“F&M”) wishes to take advantage of the Safe Harbor provisions included in the Private Securities Litigation Reform Act of 1995. Statements by F&M, including management’s expectations and comments, may not be based on historical facts and are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21B of the Securities Act of 1934, as amended. Actual results could vary materially depending on risks and uncertainties inherent in general and local banking conditions, competitive factors specific to markets in which F&M and its subsidiaries operate, future interest rate levels, legislative and regulatory decisions or capital market conditions. F&M assumes no responsibility to update this information. For more details, please refer to F&M’s SEC filing, including its most recent Annual Report on Form 10-K and quarterly reports on Form 10-Q. Such filings can be viewed at the SEC’s website, www.sec.gov.

Company Contact: Investor and Media Contact:
Amy Cover
Vice President – Marketing Manager
Farmers & Merchants Bancorp, Inc.
(419) 445-3501 ext. 15436
[email protected] 		 Andrew M. Berger
Managing Director
SM Berger & Company, Inc.
(216) 464-6400
[email protected] 



Posted on

IVC Telecom Launches New Service in Northern Ontario

MONTRÉAL, Nov. 25, 2020 (GLOBE NEWSWIRE) — In hopes to provide more Canadians affordable and reliable internet services IVC Telecom has recently announced the launch of its unlimited Internet service in Northern Ontario, in areas such as Thunder Bay, Saulte Ste Marie and Kenora. This initiative is in addition to its existing affordable unlimited high-speed Internet packages, and to guarantee customer service that meets the expectations of its users.

“For the launch of our Internet service in Northern Ontario, we plan not only to expand our services, but to also help users benefit from the best offers. For this reason, we have decided to introduce a 75 Mbps Internet package for less than $40 without commitment, to ensure the best possible pricing in the market,” says Vipin Kumar, Customer Service Manager.

IVC Telecom is a young Internet service provider trying to disrupt the status quo of the internet service industry in Canada. After decades of dealing with high prices, slow internet speeds and unreliable customer service, IVC has decided to lead by example and introduce attractive promotional offers with quality customer service tailored to the needs of each user. In order to bring the internet service provider closer to its customers, IVC has recently launched a new mobile app, as well as a modernized website to ensure the best experience for its customers.

In addition to its affordable internet service, IVC Telecom will also be introducing its residential telephone service soon, allowing its customers to communicate freely without having to worry about extra charges. “Unlike other telecom companies, our goal is to adapt to the evolution of technology while offering flexible service tailored to each of our customer’s needs,” says Vipin Kumar, Customer Service Manager.

About IVC Telecom

IVC Telecom is an independent internet service provider, founded in 2016 and based in Quebec, Canada with the promise to provide affordable, reliable and the fastest internet and home phone services. IVC came into existence with the simple act of giving back to the community. IVC Telecom’s mission is to provide the best quality services at a reasonable price while treating our customers with the utmost respect.

Link: https://www.ivctel.com/promotion/northern-ontario

SOURCE IVC Telecom Inc

Media contacts

Management of Public Relations, IVC Telecom

[email protected]



Posted on

SomaLogic Closes $121M Series A Financing Led by Casdin Capital

Capital raise will support expansion and commercialization of leading proteomics platform serving life science and clinical markets

BOULDER, Colo., Nov. 25, 2020 (GLOBE NEWSWIRE) — SomaLogic, Inc., global leader in proteomic discovery and applications transforming biomedical discovery and clinical diagnostics, announced today that the Company has successfully closed an Initial Series A capital raise of $121 Million. The Company anticipates that additional closings will occur within the next 90 days.

The Series A financing round is being led by leading life science investor Casdin Capital, with participation from Farallon Capital Management, Foresite Capital, funds and accounts advised by T. Rowe Price Associates, Inc., Blue Water Life Science Advisors, Madryn Asset Management, Fiscus Ventures and Reimagined Ventures (affiliates of Magnetar Capital), Monashee Investment Management, Mossrock Capital, Soleus Capital and others. Eli Casdin of Casdin Capital will be joining the SomaLogic Board of Directors.

The funds raised in this Series A round will facilitate improving, expanding and commercializing SomaLogic’s world-leading proteomic products in both the clinical and life science markets. SomaLogic’s total funding from inception now exceeds $485 million and has been provided largely by both financial and strategic investors.

SomaLogic’s SomaScan® Platform technology offers life science researchers from biopharmaceutical to academic labs unparalleled and reliable coverage of the proteome for revealing new biology and/or identifying new drug targets as well as the effects of current and potential new drug treatments. The Company’s growing menu of clinically relevant SomaSignal™ tests are delivering a new paradigm of empowering clinicians and individuals to more effectively manage health in real time, with a powerful and first-in-class set of proteomics-based diagnostic tools.

Roy Smythe, M.D., Chief Executive Officer of SomaLogic, stated:  “This strong vote of confidence by Casdin Capital, together with  a premier syndicate of sophisticated health care technology investors validates the  importance of the science of proteomics in both clinical and research settings and confirms SomaLogic has developed the leading technology and applications in this field.”  Dr. Smythe added:  “With this funding, we will build on our substantial technological lead in this space, continue to develop these important markets and in the process, achieve our goals of improving human health and healthcare delivery. ” Eli Casdin, Chief Investment Officer and Founder of Casdin commented,  “The proteomics era is here. We’ve invested in support of the value created by genomic technologies from the beginning. This impact has been profound across and beyond healthcare, but what has remained is the fundamental appreciation that the proteome holds as much or greater promise. These disruptive waves begin with powerful enabling technologies, and we’re seeing the emergence of these tools to power a proteomics revolution. SomaLogic is a pioneer in the space with established partnerships with leading biopharma and health system players, and we see tremendous opportunity to drive this field forward in partnership with the SomaLogic team.”

Cowen served as sole placement agent to SomaLogic for the private placement, and Reed Smith LLP served as legal counsel for the transaction.

###

About SomaLogic

SomaLogic seeks to deliver precise, meaningful, and actionable health-management information that empowers individuals worldwide to continuously optimize their personal health and wellness throughout their lives. This essential information, to be provided through a global network of partners and users, is derived from SomaLogic’s precise, proprietary, and personalized measurement of important changes in an individual’s proteins over time. For more information, visit www.somalogic.com and follow @somalogic on Twitter.

SomaSignal™ tests are developed and performance characteristics determined by SomaLogic, Inc., and SomaLogic is a Clinical Laboratory Improvement Amendments (CLIA) certified laboratory. SomaSignal™ tests have not been cleared or approved by the US Food and Drug Administration.

 



Laura Mizoue
SomaLogic, Inc.
720-417-7509
[email protected]

Posted on

Scott+Scott Attorneys at Law LLP Alerts Investors to December 4 Lead Plaintiff Deadline in Securities Class Actions Against Precigen, Inc. (PGEN)

Scott+Scott Attorneys at Law LLP Alerts Investors to December 4 Lead Plaintiff Deadline in Securities Class Actions Against Precigen, Inc. (PGEN)

NEW YORK–(BUSINESS WIRE)–Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, reminds investors that class action lawsuits are pending against Precigen, Inc. (“Precigen” or the “Company”) (NASDAQ: PGEN) (formerly Intrexon Corp. (NYSE: XON)) and certain of its officers and directors alleging violations of federal securities laws. If you purchased or otherwise acquired Precigen securities between May 10, 2017 and September 25, 2020, both dates inclusive (the “Class Period”), and have suffered losses, you are encouraged to contact Rhiana Swartz for additional information at (844) 818-6980 or [email protected].

Precigen operates in the synthetic biology field and creates biologically-based products.

The complaints allege that, throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company was using pure methane as feedstock for its announced yields for its methanotroph bioconversion platform instead of natural gas; (2) yields from natural gas as a feedstock were substantially lower than the aforementioned pure methane yields; (3) due to the substantial price difference between pure methane and natural gas, pure methane was not a commercially viable feedstock; (4) the Company’s financial statements for the quarter ended March 31, 2018 were false and could not be relied upon; and (5) the Company had material weaknesses in its internal controls over financial reporting.

On March 2, 2020, the Company filed a Form 10-K for the year ended December 31, 2019, stating that the Securities and Exchange Commission’s (“SEC”) Division of Enforcement issued a subpoena “informing the Company of a non-public, fact-finding investigation concerning the Company’s disclosures regarding its methane bioconversion platform,” but that “the investigative work was largely completed.”

On this news, the stock dropped over 17% to close at $3.24 on March 3, 2020.

Then, on September 25, 2020, the SEC announced a cease and desist order against Precigen. The cease and desist order involved “inaccurate reports concerning the Company’s purported success converting relatively inexpensive natural gas into more expensive industrial chemicals using a proprietary methane bioconversion (“MBC”) program.” The order noted that the Company was “primarily using significantly more expensive pure methane for the relevant laboratory experiments but was indicating that the results had been achieved using natural gas.”

What You Can Do

If you purchased Precigen securities between May 10, 2017 and September 25, 2020, both dates inclusive, and have suffered losses, or if you have questions about this notice or your legal rights, you are encouraged to contact attorney Rhiana Swartz for additional information at (844) 818-6980 or [email protected]. The lead plaintiff deadline is December 4, 2020.

About Scott+Scott Attorneys at Law LLP

Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Connecticut, California, and Ohio.

Attorney Advertising

Rhiana Swartz

Scott+Scott Attorneys at Law LLP

(844) 818-6980

[email protected]

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Legal Professional Services

MEDIA:

Logo
Logo
Posted on

Consolidated Communications to Present at the Wells Fargo TMT Summit

MATTOON, Ill., Nov. 25, 2020 (GLOBE NEWSWIRE) — Consolidated Communications Holdings, Inc. (Nasdaq: CNSL), a leading broadband and business communications provider, today announced that Bob Udell, president and chief executive officer, will present at the Wells Fargo TMT Summit on Tuesday, Dec. 1 at 8:40 a.m. ET. Consolidated will also host one-to-one meetings.

A live webcast and presentation materials will be available on the Company’s Investor Relations website at https://ir.consolidated.com/.

About Consolidated Communications
Consolidated Communications Holdings, Inc. (NASDAQ: CNSL) is a leading broadband and business communications provider serving consumers, businesses, and wireless and wireline carriers across rural and metro communities and a 23-state service area. Leveraging an advanced fiber network spanning 46,300 fiber route miles, Consolidated Communications is a top-10 fiber provider in the U.S. offering a wide range of communications solutions, including: high-speed Internet, data, phone, security, managed services, cloud services and wholesale, carrier solutions. From our first connection 125 years ago, Consolidated is dedicated to turning technology into solutions, connecting people and enriching how they work and live. Visit www.consolidated.com for more information.

Contact:                                                   
Jennifer Spaude, Consolidated Communications
Phone: 507-386-3765
[email protected]

 



Posted on

BRY INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Berry Corporation

PR Newswire

NEW YORK, Nov. 25, 2020 /PRNewswire/ — Bernstein Liebhard, a nationally acclaimed investor rights law firm, announces that a securities class action lawsuit has been filed on behalf of investors who purchased or acquired the securities of Berry Corporation (“Berry” or the “Company”) (NASDAQ: BRY) (i) in connection with the Initial Public Offering (“IPO”) on July 26, 2018; and/or (ii) from July 26, 2018 through November 3, 2020 (the “Class Period”). The lawsuit filed in the United States District Court for the Northern District of Texas alleges violations of the Securities Act of 1933 and the Securities Exchange Act of 1934.

If you purchased Berry securities, and/or would like to discuss your legal rights and options please visit Berry Shareholder Class Action Lawsuit or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected]

The complaint alleges that the Offering Documents, and, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Berry had materially overstated its operational efficiency and stability; (2) Berry’s operational inefficiency and instability would foreseeably necessitate operational improvements that would disrupt the Company’s productivity and increase costs; (3) the foregoing would foreseeably negatively impact the Company’s revenues; and (4) as a result, the Offering Documents and the Company’s public statements were materially false and/or misleading and failed to state information required to be stated therein.

On November 3, 2020, post-market, Berry reported its financial and operating results for the third quarter of 2020. Among other results, Berry reported non-GAAP EPS and revenue that both fell short of estimates. In addition, Berry reported that during the quarter, “the Company undertook certain operational improvements that caused temporary reductions in our production. Notably we performed some plugging and abandonment activity that resulted in temporary shut-in of nearby wells. Additionally, improved steam management reduced overall costs but temporarily increased water disposal and well maintenance needs, resulting in a slight decrease in production.”

On this news, Berry’s stock price fell $0.15 per share, or 5.28%, to close at $2.69 per share on November 4, 2020, representing an 80.78% decline from the IPO price.

If you wish to serve as lead plaintiff, you must move the Court no later than January 21, 2021. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

If you purchased Berry securities, and/or would like to discuss your legal rights and options please visit https://www.bernlieb.com/cases/berrycorporation-bry-shareholder-class-action-lawsuit-fraud-stock-336/apply/ or contact Matthew E. Guarnero toll free at (877) 779-1414 or [email protected]

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of lawsuits and class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for ten consecutive years.

ATTORNEY ADVERTISING. © 2020 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Michael S. Bigin. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information

Matthew E. Guarnero

Bernstein Liebhard LLP
https://www.bernlieb.com
(877) 779-1414
[email protected]

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/bry-investor-alert-bernstein-liebhard-llp-announces-that-a-securities-class-action-lawsuit-has-been-filed-against-berry-corporation-301180660.html

SOURCE Bernstein Liebhard LLP